Skip to content

ANI Pharmaceuticals

US · ANIP #2919 by market cap Listed 1970
68.55 -0.58 -0.84%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Rating change
    Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating
    Market Newswire · 2026/5/11
  • H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121
    Market Newswire · 2026/11/6
  • J.P. Morgan Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)
    TipRanks · 2026/10/22
  • Rating change
    Barclays Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/8/26
  • CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $90
    Market Newswire · 2026/11/6
  • Rating change
    Leerink Partners Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $104
    Market Newswire · 2026/9/9
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2025/11/10
  • Rating change
    Truist Financial Downgrades ANI Pharmaceuticals(ANIP.US) to Hold Rating
    Market Newswire · 2025/11/10
  • Rating change
    CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $91
    Market Newswire · 2026/7/17
  • J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
    Market Newswire · 2026/10/22
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
    Market Newswire · 2026/1/13
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $119
    Market Newswire · 2026/10/6
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $124
    Market Newswire · 2026/7/14
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Cuts Target Price to $119
    Market Newswire · 2026/8/10
  • Rating change
    CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Cuts Target Price to $90
    Market Newswire · 2026/8/10
  • Rating change
    Piper Sandler Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $111
    Market Newswire · 2026/4/23
  • Rating change
    CCORF Downgrades ANI Pharmaceuticals(ANIP.US) to Hold Rating, Raises Target Price to $91
    Market Newswire · 2026/7/17
  • Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $121
    Market Newswire · 2026/11/6
  • Rating change
    Jefferies Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/3/25
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $124
    Market Newswire · 2026/1/16
  • H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121
    Market Newswire · 2026/9/22
  • Rating change
    Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $114
    Market Newswire · 2025/10/28
  • Rating change
    Leerink Partners Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $103
    Market Newswire · 2025/10/15
  • Rating change
    J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
    Market Newswire · 2026/8/10
  • Rating change
    J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2025/9/24

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:05 · For reference only, not investment advice and not tailored to your situation.

ANI Pharmaceuticals discussion 0 comments

Add a comment